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Abstract
Thousands of regions in gametes have opposing methylation profiles that are largely
resolved during the post-fertilization epigenetic reprogramming. However some specific
sequences associated with imprinted loci survive this demethylation process. Here we
present the data describing the fate of germline-derived methylation in humans. With the
exception of a few known paternally methylated germline differentially methylated regions
(DMRs) associated with known imprinted domains, we demonstrate that sperm-derived
methylation is reprogrammed by the blastocyst stage of development. In contrast a large
number of oocyte-derived methylation differences survive to the blastocyst stage and
uniquely persist as transiently methylated DMRs only in the placenta. Furthermore, we
demonstrate that this phenomenon is exclusive to primates, since no placenta-specific
maternal methylation was observed in mouse. Utilizing single cell RNA-seq datasets from
human preimplantation embryos we show that following embryonic genome activation the
maternally methylated transient DMRs can orchestrate imprinted expression. However
despite showing widespread imprinted expression of genes in placenta, allele-specific tran-
scriptional profiling revealed that not all placenta-specific DMRs coordinate imprinted
expression and that this maternal methylation may be absent in a minority of samples, sug-
gestive of polymorphic imprinted methylation.
PLOS Genetics | DOI:10.1371/journal.pgen.1006427 November 11, 2016 1 / 23
a11111
OPENACCESS
Citation: Sanchez-Delgado M, Court F, Vidal E,
Medrano J, Monteagudo-Sánchez A, Martin-Trujillo
A, et al. (2016) Human Oocyte-Derived Methylation
Differences Persist in the Placenta Revealing
Widespread Transient Imprinting. PLoS Genet
12(11): e1006427. doi:10.1371/journal.
pgen.1006427
Editor: Marisa S Bartolomei, University of
Pennsylvania, UNITED STATES
Received: June 22, 2016
Accepted: October 14, 2016
Published: November 11, 2016
Copyright: © 2016 Sanchez-Delgado et al. This is
an open access article distributed under the terms
of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This work was supported by Spanish
Ministerio de Educación y Competitividad
(MINECO) (BFU2014-53093 to DM) co-funded
with the European Union Regional Development
Fund (FEDER). AMS is a recipient of a FPI PhD
studentship from MINECO. TMB is supported by
ICREA, EMBO YIP 2013, MINECO BFU2014-
55090-P (FEDER), BFU2015-7116-ERC and
Author Summary
Differences in gamete DNA methylation is subject to genome-wide reprogramming dur-
ing preimplantation development to establish an embryo with an epigenetic state compati-
ble with totipotency. DNA sequences associated with imprinted differentially methylated
regions (DMRs) are largely protected from this process, retaining their parent-of-origin
epigenetic marks. By comparing the methylation profiles of human oocytes, sperm, blasto-
cysts and various somatic tissues including placenta, we observe hundreds of CpG island
sequences that maintain methylation on their maternal allele in blastocysts and placenta
indicative of incomplete reprogramming. In some cases this maternal methylation influ-
ence transcription of nearby genes, revealing transient imprinting in embryos after
genome-activation and in placenta. Strikingly, these placenta-specificDMRs are polymor-
phic between placenta samples with a minority of samples being robustly unmethylated
on both alleles.
Introduction
In mammals, DNA methylation of CpG dinucleotides has been shown to play critical roles in
many developmental processes including cellular differentiation, X chromosome inactivation
and genomic imprinting. DNA methylation patterns are initially established by the de novo
DNA methyltransferase DNMT3A [1], with the methylation profile faithfully maintained dur-
ing DNA replication by the maintenance methyltransferase DNMT1-UHRF1 complex [2].
It has recently been shown that the gametes from both mouse and humans possess large
intervals of opposing methylation [3–7]. Within a few hours after fertilization, a wave of global
epigenetic reprogramming ensures that methylation at the blastocyst stage is at their lowest
level, erasing the majority of this gametic epigenetic information [3, 5, 7]. However, some spe-
cific sequences survive this demethylation process, specifically those located within imprinted
regions and certain repeat subtypes. Imprinted genes are only transcribed from one parental
allele leading to parent-of-origin specific expression, with allelic expression directly controlled
by allelic methylation [8]. To date all imprinted domains contain at least one differentially
methylated region (DMR) that acquires methylation during gametogenesis (germlineDMR, or
gDMR), and maintained throughout development. Some imprinted loci also contain DMRs
that become allelicallymethylated in the embryonic diploid genome (somatic DMRs, or
sDMR) which are under the hierarchical influence of gDMRs [4, 9, 10]. Recently, transiently
methylated germlineDMRs (tDMRs) have been identified in mice that are indistinguishable
from ubiquitous imprinted gDMRs in gametes and preimplantation embryos [11]. The mater-
nally methylated tDMRs described in mouse subsequently gain methylation on their paternal
alleles at implantation, having first survived the post-fertilizationdemethylation process. This
reprogramming to a totipotent state starts in the male pronucleus with TET3-mediated conver-
sion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) [12] with subsequent
replication-dependent dilution of methylation of both maternal and paternal genomes occur-
ring during the first 2 days of human development [5, 7, 13]. Unlike mice, in humans it is cur-
rently unknown how many germline differences survive embryonic reprogramming and
persist in humans, either as ubiquitous imprinted gDMRs or tDMRs. However initial screens
suggest that oocyte-derivedtDMRs may be present to the blastocyst stage [7, 14].
Here, we present the data describing the fate of germline-derivedmethylation in humans.
Using publically available methyl-seq datasets from gametes, preimplantation embryos, pla-
centa and somatic tissues, we identify 53,549 methylation differences between gametes, the
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majority beingmethylated in the sperm and not in oocytes.With the exception of a few pater-
nally methylated gDMRs associated within known imprinted domains, we demonstrate that
sperm-derivedmethylation is reprogrammed by the blastocyst stage. In contrast a large num-
ber of oocyte-derivedmethylation differences survive to the blastocyst stage, persisting as
maternally methylated DMRs in the placenta only, expanding the number of placenta-specific
DMRs reported using high-density array based screens [10, 15–17]. Furthermore, we demon-
strate that this phenomenon is exclusive to humans and non-human primates since no pla-
centa-specificmaternal methylation was observed in other mammalian species. Utilizing single
cell RNA-seq datasets from human preimplantation embryos [18] we show that following
embryonic genome activation the maternally methylated gDMRs orchestrate imprinted
expression in preimplantation embryos. However, despite showing imprinted expression of
many genes, transcriptional profiling revealed that not all placenta-specificmaternally methyl-
ated DMRs coordinate imprinted expression suggesting differential reading of this epigenetic
mark during human embryonic development.
Results
Identification of persisting gDMRs in preimplantation human embryos
Transient maternally inheritedmonoallelicmethylation has been previously observed in
mouse. To identify candidate loci in humans we searched for regions that are differentially
methylated between sperm and oocytes.Using defined criteria (see methods) we identified 5,
438 oocytes and 48, 111 sperm-derivedDMRs.
A high proportion of regions methylated in sperm and hypomethylated in oocyteswere
intergenic or map to repeat elements, consistent with previous observations [5]. In contrast,
oocyte-specificDMRs were more uniformly distributed throughout the genome, often overlap-
ping promoter CpG islands. Eighty percent of the oocyte-derivedDMRs (n = 4, 352) remain
partiallymethylated at the blastocyst stage, which is consistent with methylation dynamics dur-
ing the progression of cleavage stage embryos to blastocysts [6, 7] with very few sperm-derived
DMRs surviving to the blastocyst stage (1%, n = 517) (Fig 1A and 1B). This reprogramming is
particularly evident when the size of the gDMRs surviving to the blastocyst stage is taken into
consideration. In total ~7 Mb of the human genome encompasses oocyte-derivedgDMRs of
which 74% is hemimethylated in preimplantation embyros, whereas ~2.7 Mb is covered by
sperm-derived gDMRs of which only 11% is hemimethylated at the same developmental stage.
Therefore, maternal gDMRs are lost after the blastocyst stage whereas the methylation at pater-
nal gDMRs is largely removed during preimplantation stages, possible occurringbefore the
first cleavage division arguing against a simple replication-dependent demethylation of the
maternal genome during preimplantation development.
Selected survival of imprinted DMRs
Numerous studies have shown that gDMR that persist uniformly in somatic tissues act as
imprinting control regions. To date 49 ubiquitous imprinted DMRs have been identified in
humans using high-density methylation arrays [10]. To determine if additional imprinted
DMRs are present in the human genome, we determined the methylation profile of the oocyte
and sperm-derived gDMRs that are present with preservedmethylation in methyl-seq datasets
in blastocysts, placenta and 14 different somatic tissues.We observe only one sperm-derived
regionmapping to a known paternally methylated DMR in> 12 tissues, theH19 gDMR on
chromosome 11. The only additional known paternally methylated DMR originating from
sperm in humans, the IG-DMR on chromosome 14, was differently methylated between gam-
etes but was partiallymethylated in blastocysts and five somatic tissues only. Using the same
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Fig 1. Methylation profiling of human gametes, embryos and tissues. (A) Heatmap of all 25 CpG dinucleotide tiles with maternal
(left) and paternal (right) germline-derived methylation maintaining an intermediate state in blastocysts and arranged in descending
order according to their placenta methylation profile. Tiles were partitioned according to their hypo- (<20%), hyper- (>80%) or
intermediate (>20%, <80%) methylation. Genomic features are included as separate heatmaps. (B) Violin plots classified as the %
repetitive sequences per 20 CpG dinucleotide tile for the paternally methylated, maternally methylated and known imprinted DMRs.
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criteria we observe 60 oocyte-derivedDMRs in>12 tissues, including 25 knownmaternally
methylated imprinted DMRs (S1 Table). Of the remaining intervals not associated with known
imprinted gDMRs, we confirm FANCC and SVOPL as being novel ubiquitous imprints (S1 Fig;
Fig 1C and 1D). Using allele-specificRT–PCR that incorporated a coding SNP within exon 5,
we observedmaternal expression of SVOPL in placenta and monoallelic expression in brain
and leukocytes (Fig 1E). Unfortunately we could not identify any informative samples to allow
for the allelic expression of FANCC to be ascertained.
Identification of widespread maternally methylated placenta-specific
DMRs
To determine if germline-derivedDMRs are maintained in a tissue-specific fashion we
screened for loci partiallymethylated in only one tissue (Fig 2A and 2B). This analysis revealed
that 551 of the partiallymethylated regions in blastocysts inheritingmethylation from the
oocyte survived only in the placenta, whereas only 38 regions inheritingmethylation from
spermwere identified in this extra-embryonic tissue (S2 Table). Since standard bisulphite con-
version based technologies cannot distinguish between 5mC and 5hmC, we utilizedmethyla-
tion-sensitive genotyping assays that can distinguish these two forms based on the addition of
a glucosemoiety to yield glucosyl-5-hydroxymethylcytosine. This, combined with allele-spe-
cific bisulphite PCR, revealed no novel paternally methylated placenta-specific gDMRs since
all candidates were mosaically methylated, but maternal placenta-specific gDMRs were abun-
dant and specifically associated with 5mC (S2, S3 and S4 Figs; S2 and S3 Tables).
The fate of 5mC at maternal placenta-specific gDMRs in somatic tissues was largely influ-
enced by sequence content. The confirmed placenta-specificmaternal methylation regions
were almost always high CG content intervals robustly unmethylated in somatic tissues,
whereas hypermethylated loci in somatic tissues were often false positives being partiallymeth-
ylated regardless of the parental allele, with the exceptions of four loci which we confirm as
maternally methylated (TMEM247,GPR1-AS1, ZFAT, and C19MC) (S5 and S6 Figs) [19, 20].
This reflects the general methylation status of the placenta, which is relatively hypomethylated
across the genome, including repeat elements [21, 22]. For example the GRID2 gene is associ-
ated with two maternally methylated gDMRs with different genomic content. The promoter
CpG island is robustly methylated on the maternal allele in placenta and is unmethylated in
somatic tissues, whereas an intergenic region within intron 3, consisting of an Alu/SINE repeat,
is a gDMR with a mosaic methylation profile in placenta that is fully methylated in all somatic
tissues (Fig 2C and 2D).
We observe robust maternal methylation associated with multiple members of two large
gene families, the fibroblast growth factors (FGF8, FGF12 and FGF14) and calcium channel,
voltage-dependent channel subunits (CACNA1A, CACNA1C, CACNA1E and CACNA1I) as
well as several gene involved in epigenetic regulation (JMJD1C and DNMT1) and microRNA
processing (LIN28B and EIF2C1) (S3 and S4 Figs). These results therefore reveal that placenta-
specific gDMRs are much more abundant in the human genome than previously reported.
The numbers in red represent the tiles with unique sequences (defined as >25% repeats). (C) Two novel maternally methylated
ubiquitous DMRs associated with the SVOPL and FANCC genes exhibit promoters that are unmethylated in sperm, hypermethylated
in oocytes and intermediately methylated in blastocysts, placenta and somatic tissue in methyl-seq datasets. The vertical black lines in
the methyl-seq tracks represent the mean methylation value for individual CpG dinucleotides. Green boxes highlight the position of the
gDMRs. (D) Bisulphite PCR and subcloning was used for confirmation. Each circle represents a single CpG dinucleotide on a DNA
strand. (•) Methylated cytosine, (o) unmethylated cytosine. Each row corresponds to an individual cloned sequence. If heterozygous
for a SNP, the parental-origin of methylation is indicated. For clarity only the first 10 CpG dinucleotides are shown. (E) Allelic RT-PCR
for SVOPL reveals transcription from the maternal allele in placenta and monoallelic expression in brain and leukocytes.
doi:10.1371/journal.pgen.1006427.g001
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Fig 2. Analysis of tissue-specific maintenance of germline methylation in different tissues. (A) A bar graph showing the fate of gDMRs in
tissues. The bars represent the profiles of known ubiquitous (black) and placenta-specific (orange) gDMRs with numbers corresponding to the
left y-axis. The superimposed line graph represent the profile of all remaining germline difference that are maintained to the blastocyst stage and
correspond to the right y-axis. * placenta-specific DMRs identified by Court (2014) [10] and Sanchez-Delgado (2015) [15]. (B) A pie graph
showing the distribution of individual tissues maintaining a partially methylated profile. (C) The GRID2 gene exhibits high inter- and intragenic
methylation and several regions with oocyte-derived methylation. The methyl-seq data reveals that a 1.9 kb region overlapping the promoter
remains an imprinted gDMR in placenta while it is demethylated in all other tissues. A second oocyte-derived gDMR, consisting largely of an Alu/
SINE repeat, becomes fully methylated in all tissues analysed. The vertical black lines in the methyl-seq tracks represent the mean methylation
value for individual CpG dinucleotides. A green box highlights the position of the gDMR. (D) Bisulfite PCR and subcloning on heterozygous
placenta DNA samples for the GRID2 promoter and intragenic regions. Each circle represents a single CpG dinucleotide on a DNA strand. (•)
Methylated cytosine, (o) unmethylated cytosine. Each row corresponds to an individual cloned sequence. If informative for a SNP, the parental-
origin of methylation is indicated. For clarity only the first 10 CpG dinucleotides are shown.
doi:10.1371/journal.pgen.1006427.g002
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Confirmation of germline profiles and methylation asymmetries in
human embryos
Using nested-multiplex bisulphite PCR, we confirmed the methylation profiles of four ubiqui-
tous imprinted gDMRs (H19,MCTS2, FANCC, SVOPL) and 13 placenta-specific gDMRs in
sperm and blastocystsmicosurgically separated into inner cell mass (ICM) and trophectoderm
(TE) (Fig 3 and S4 Fig). The R3HCC1 loci on chromosome 8 exemplified the fate of opposing
germlinemethylation difference as this gene has adjacent oocyte and sperm-derived gDMRs.
Using bisulphite PCR we show that the maternally methylated gDMR is observed in ICM/TE
and term placenta, whereas the paternally methylated gDMR, which was not identified in our
initial genome-wide screen since it does not reach our screening criteria having< 25 CpGs,
resolves to a mosaic methylated state at the blastocysts stage (Fig 3C and 3D).
Placenta-specific gDMR are largely confined to primates
We have previously shown that 14 orthologs of maternally methylated placenta-specificDMRs
are devoid of methylation in the mouse placenta [10]. Using methyl-seq datasets frommouse
placenta with bisulphite PCR confirmation we show that no human placenta-specificDMRs
are conserved in mice (S7A and S7B Fig). Similarly the mouse orthologous regions correspond-
ing to the SVOPL and FANCC DMRs also lack allelic methylation and are biallelically
expressed in multiple tissues (S7B Fig). Several studies have shown that maternally methylated
gDMRs mark different loci in mouse compared to humans [3, 5], suggesting that the mouse
genomemay possess a unique set of placenta-specificDMRs inherited from the female germ-
line. We therefore determined the fate of oocyte-derivedgDMRs in hybrid mouse placenta.
Consistent with our previous observation, no maternal gDMRs persist as placenta-specific
DMRs, reinforcing that this phenomenon is not observed in mice (S7C Fig). Recently methyl-
seq datasets have been produced from different mammalian species, including rhesus macaque,
horse, cow and dog [23]. Similar to mouse, the orthologues of the vast majority of human pla-
centa-specific gDMRs do not have a methylation profile consistent with imprinting in non-pri-
mate species (S7A Fig). Using bisulphite PCR on DNA derived from rhesus placenta, we
confirm evolutionary conservation of 63% placenta-specificDMRs as well as those associated
with the ubiquitously imprintedMCTS2,GRB10 and L3MBTL1 genes (S7D Fig).
Allele-specific expression analysis of transcripts associated with
placenta-specific gDMRs
The main biological significance of promoter methylation is thought to be transcriptional
repression of tissue-specific genes, with methylation levels negatively correlated with expres-
sion following genome activation at the 8 cell stage [6]. To determine if maternal-specificmeth-
ylation at placenta-specific gDMRs dictates paternal expression we performed allele-specific
RT-PCR in placenta. Paternal expression was confirmed for nine genes includingAGO1, USP4,
SH3BP2, FAM149A,MOCS1,R3HCC1, JMJD1C,PAK1 and PAPLN-AS (Fig 4A; S4 Table).
Curiously however, we observe that not all informative placenta samples exhibited monoallelic
expression despite maintaining robust maternal methylation (Fig 5A, S4 and S8 Figs; S4
Table). We also observe paternal expression of a ~10 kb non-coding (nc)RNA overlapping a
placenta-specific gDMR located 12 kb 3’ to TET3 (Fig 4B–4D). To determine if this ncRNA
influences expression in cis, we performed allelic RT-PCR for TET3. We observe biallelic
expression of TET3 suggesting that the neighboring ncRNA does not possess enhancer or
repressive function in term placenta (Fig 4D). In total this bringing the total number of con-
firmed placenta-specific paternally expressed genes to more than 30 [8, 16].
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Fig 3. Methylation profiling of opposing gDMRs using bisulphite PCR in human gametes and blastocysts. (A) The confirmation that the H19
DMR acquires methylation from the sperm and maintains in preimplantation embryos (separated into ICM and TE) and in somatic tissues. The MSCT2
DMR shows the opposite profile with sperm devoid of methylation. (B) The bisulphite PCR profiles for the novel ubiquitous FANCC and SVOPL DMRs in
human sperm, blastocysts and placenta. (C) Methyl-seq datasets reveal that the R3HCC1 gene has two adjacent gDMRs, an upstream paternal gDMR
(region 1) that subsequently gains methylation on both alleles during the blastocyst stage and a placenta-specific maternally methylated promoter region
(region 2). The vertical black lines in the methyl-seq tracks represent the mean methylation value for individual CpG dinucleotides. Green boxes highlight
the position of the gDMRs. (D) Confirmation of the methylation profile by bisulfite PCR and subcloning. Each circle represents a single CpG dinucleotide
on a DNA strand. (•) Methylated cytosine, (o) unmethylated cytosine. Each row corresponds to an individual cloned sequence. If informative, the
parental-origin of methylation is indicated. For clarity only the first 10 CpG dinucleotides are shown.
doi:10.1371/journal.pgen.1006427.g003
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Fig 4. Analysis of allelic expression for genes associated with novel placenta-specific maternally methylated gDMRs. (A) Allelic
RT-PCR analysis for nine transcripts originating from placenta-specific DMRs in control placenta samples. Monoallelic paternal expression was
observed in heterozygous placenta biopsies. (B) The identification of a ~10 kb ncRNA overlapping a placenta-specific gDMR ~12 kb downstream
of the TET3 gene. The vertical black lines in the methyl-seq tracks represent the mean methylation value for individual CpG dinucleotides. The
green box highlights the position of the gDMRs. (C) The 2.7 kb maternally methylated placenta-specific DMR identified by methyl-seq and
confirmed with allelic-specific bisulphite PCR and subcloning. Each circle represents a single CpG dinucleotide on a DNA strand. (•) Methylated
cytosine, (o) unmethylated cytosine. Each row corresponds to an individual cloned sequence. For clarity only the first 10 CpG dinucleotides are
shown. (D) Paternal expression of the RNA-seq peak was determined by RT-PCR, whilst allele-specific RT-PCR revealed that TET3 is
biallelically expressed in term placenta samples.
doi:10.1371/journal.pgen.1006427.g004
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Fig 5. Allele-specific expression and methylation analysis of genes with variable maternal placenta-specific gDMRs. (A)
Allelic RT-PCR analysis for SH3BP2 and MOCS1 in placenta samples with bisulphite PCR and subcloning of the associated gDMR in
the same biopsy. Each circle represents a single CpG dinucleotide on a DNA strand, a methylated cytosine (•) or an unmethylated
Persistence of Oocyte Methylation in the Human Placenta
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Widespread polymorphic maternal methylation in placenta
Polymorphic imprinting has been described for only a few loci in humans, including the
IGF2R [24, 25] and nc886/vtRNA2-1 [26, 27], with the latter consistent with being a metastable
epiallele. To determine if the placenta-specific gDMRs that we identified show variable methyl-
ation on the maternal allele, we performed pyrosequencing to quantify a larger cohort of nor-
mal placenta samples from uncomplicated pregnancies.We identified hypomethylated
samples for 12 of the regions (Fig 5B), with the most affected loci being LIN28B and AGBL3.
For samples with informative polymorphisms this lack of methylation is associated with bialle-
lic expression (Fig 5C), an observation consistent with some placenta-specificmaternal
gDMRs being a stochastic polymorphic trait [17].
Imprinted expression following embryonic genome activation in
blastocysts
It has previously been reported that a significant proportion of transcripts are monoallelically
expressed in cleavage embryo [17] indicating that maternally methylated placenta-specific
gDMRs may regulate allelic expression at this earlier developmental time point. To ascertain
if the placenta-specific gDMRs orchestrate imprinted expression, we determined allelic
expression in publically available single cell embryo RNA-seq datasets for which paternal
genotypes were available [18]. Gene expression profiles were analyzed in individual embryos
to determine the progression of expression levels and their allelic origin. To compare
embryos at different stages it is important to take into consideration two events, embryonic
genome activation and oocyte-derived transcript degradation. Zygotic genome activation
(ZGA) occurs soon after fertilization (pre-major ZGA) and processed in successive waves of
activation with the major changes reported at the 4–8 cell stage [28]. Maternal transcript
stores in the oocyte cytoplasm are diminished after fertilization by a combination of degrada-
tion and recruitment to the polysome and translated prior to ZGA [29]. Transcripts highly
abundant at the pronuclear stage and decreasing as developmental proceeds will not be
expressed from the embryonic genome and will appear maternally derived. Embryonically
transcribed genes that maintain high expression levels from the pronuclear stages would
appear maternally expressed before 8-cell stage, switching to imprinted paternal expression
with RNA synthesis from the unmethylated allele if the gDMRs are functional. Some
instances of biallelic expression maybe wrongly classified since embryonic paternal expres-
sion and oocyte-derived transcripts may co-exist until late cleavage stage. Finally, genes that
are activated during cleavage embryo development, but not originally expressed in the zygote
are predicted to be from the paternal allele. Therefore functional paternal expression can
only be categorized after genome activation (Fig 6A). Using these criteria we screened all
transcripts near the oocyte-derivedgDMRs for imprinting and observed, as proof of princi-
pal, the paternal expression of ZHX3 in 8-cell and morula and confirm preferential paternal
expression arising from a maternally methylated promoter in multiple term placenta biopsies
(Fig 6B–6E).
cytosine (o). For clarity only the first 10 CpG dinucleotides are shown. (B) Pyrosequencing quantification of 29 placenta-specific DMRs
reveals hypomethylation indicative of a stochastic trait. The average methylation of 55 controls placenta samples from uncomplicated
pregnancies reveals profiles consistent with one methylated and unmethylated allele. The controls represented as Tukey box-and-
whisker plots with whiskers spanning from 25th to 75th percentiles +/- 1.5IQR to highlight outliers. Individual hypomethylated samples
are highlighted. (C) Allelic specific RT-PCR and strand-specific bisulphite PCR and subcloning of placenta samples lacking maternal
methylation at LIN28B identified in (B) compared to a normal imprinted control sample.
doi:10.1371/journal.pgen.1006427.g005
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Fig 6. Identification of novel imprinted genes in human embryos using allele-specific RNA-seq datasets. (A) Schematic drawing of the
sequential transcriptome switching from oocyte-derived transcripts to the embryonic genome in human preimplantation embryos. (B) The
expression pattern of the ZHX3 gene during human preimplantation development. High expression was observed from the zygote to the 8-cell
stage, declining in the morula. Paternal expression as observed from the 4-cell stage onwards. (C) Allele-specific RT-PCR was performed on term
placenta samples heterozygous for the exonic SNP rs17265513. (D) Methyl-seq traces reveal the location of the placenta-specific maternal
gDMR overlapping the ZHX3 promoter. The vertical black lines in the methyl-seq tracks represent the mean methylation value for individual CpG
dinucleotides. The green box highlights the position of the gDMRs. (E) The methylation profile confirmed using bisulphite PCR and cloning in
sperm, blastocysts and placenta. Each circle represents a single CpG dinucleotide on a DNA strand. (•) Methylated cytosine, (o) unmethylated
cytosine. Each row corresponds to an individual cloned sequence. For clarity only the first 10 CpG dinucleotides are shown.
doi:10.1371/journal.pgen.1006427.g006
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Placenta-specific gDMR are reprogrammed in primordial germ cells
In addition to the reprogramming that occurs immediately after fertilizations from which
imprints are protected, reprogramming in primordial germ cells (PGCs) of the developing
fetus includes all ubiquitous imprints ensuring the transmission of genetic information with
the correct epigenetic profile in the gametes [30]. Recently, the methylomes of human PGCs of
both sexes have been generated, which confirm that human PGCs at 7–9 weeks gestation are
hypomethylated similar to those in the mouse at embryonic day 13.5 [31, 32]. Using these data-
sets, we confirm that placenta-specificDMRs are devoid of methylation in both male and
female PGCs at 10 weeks gestation and are indistinguishable from ubiquitous gDMR imprints
(S5 Table). Similar to the ubiquitous gDMR imprints, the majority of placenta-specific gDMRs
(78%) are frequently associated with CpG-rich sequences with an intragenic location with evi-
dence of a transcriptional event initiating from upstream promoters (S5 Table). This intragenic
location has been shown to be important in facilitating the acquisition of methylation during
female germline development [33, 34].
Discussion
In this study DNA methylation in human gametes, embryos, placenta and multiple somatic tis-
sues were used to identify gDMRs that may act as imprints. Using high-density methylation
arrays, our group and others have recently identified ~150 maternally methylated DMRs in
placenta [10, 15–17, 35], for which we confirm the majority are bona fide germline difference
in methylation. A comparison of the oocyte-derivedDMRs reported by Smith and colleagues
revealed largely overlapping datasets in blastocysts [7]. Using different bioinformatics criteria,
25 continuously CpGs rather than 100bp tiles, our analysis identified ~64% of previously iden-
tified loci, with missing regions possible due to inferior sequence coverage of reduced represen-
tation bisulphite sequencing or the size of the windows analyzed. Furthermore, using methyl-
seq datasets, we identify an additional 551 loci that could represent placenta-specific gDMRs,
however only 11% had high informative polymorphisms to allow for allelic discrimination.
With the exception of only four regions, these placenta-specific gDMRs are associated with
CpG islands or promoter intervals devoid of methylation in somatic tissues. Those regions ful-
filling our criteria of partiallymethylation and hypermethylated in other tissues may simply
reflect the relatively hypomethylated nature of the placenta genome that had previously hin-
dered us from performing imprinted DMR analyses in placenta methyl-seq datasets [10].
Recently, Schroeder and colleagues described that the placenta genome has unique partially
methylated domains (PMDs) that are larger (>100 kb) and have lower levels of DNA methyla-
tion than the rest of the genome, which are stable throughout gestation [21, 36]. The placenta-
specific gDMRs we describe are much smaller than PMDs having an average size of 2.2 kb with
only two (CACNA1I and ZNF385D)mapping to PMDs.
While allelic DNA methylation at ubiquitous gDMR imprints is associated with monoallelic
expression, our analysis reveals that only half of all placenta-specific gDMRs orchestrate pater-
nal expression suggesting that despite beingmaternally methylated, the maternal alleles may
not be associated with a compact chromatin state or decorated with repressive histone modifi-
cations sufficient to influence transcription. A recent genome-wide screen using diandric and
digynic triploid conceptions and RRBS datasets also identified placenta-specific gDMRs, many
overlapping with the loci we identify [17]. However, these authors did not perform any allelic
expression analyses for their candidates and so the functional relevance of this tissue-specific
methylation was not addressed. Furthermore this study revealed epigenetic stochasticity for
many of the placenta-specificDMRs described, similar to what we also observe for many of the
regions we quantified using pyrosequencing (Fig 5). However it remains to be determined
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whether lack of methylation at these loci reflects a random selection of cells not maintaining
methylation after embryonic reprogramming or alternatively, exposes loci that fail to establish
methylation in the female germline in a polymorphic fashion.
We show that allelic methylation is present in the inner cell mass and trophectodermof
human blastocysts, revealing that 5mC is selectively protected from embryonic reprogramming
and that it maintained following the first differentiation step. Furthermore, our data suggest
that an additional small wave of targeted demethylation exists following implantation in cells
specified for the somatic lineages that is absent during placenta differentiation. Very few stud-
ies have assessed allelic expression of imprinted genes in human embryos with only paternal
expression of IGF2, SNRPN andMEST being previously reported [37–39]. We show that the
placenta-specific gDMRs can influence allelic expression immediately following embryonic
genome activation as highlighted by ZHX3. Unfortunately no additional paternally expressed
genes were identified in the embryo datasets due to the lack of informative polymorphisms.
Extrapolating this observationsmeans that there are potentially thousands more transiently
imprinted genes in the blastocysts associated with the loci which get that reprogrammed after
implantation which may have a physiological role in embryonic development.
By directly assessing methylation in placenta-derivedDNA from different mammalian spe-
cies we observe that oocyte-derivedgDMRs in placenta are largely restricted to primates, being
most abundant in humans. These observations are inconsistent with recent reports that
oocyte-derivedmethylation regulates trophoblast development in the mouse [40]. However,
this study did not assess allelic methylation per se, but inferred it from various Dnmt3a/
Dnmt3b knockout crosses. The developmental phenotype observedcould be due to the deregu-
lation of only a few genes such as the maternally expressedAscl2 (previously known asMash2)
that is regulated in cis by the maternally methylated ubiquitous KvDMR1[41, 42]. Furthermore
strand-specific bisulphite PCR of several of the proposed genes responsible for this develop-
mental phenotype failed to identify methylation specifically on the maternal allele in mouse
hybrid placenta (S9 Fig).
There are no unifying explanations of how imprinted genes evolved, but there are several
theories hypothesized that underscore the importance of the placenta. The most popular theory
is associated with the parental conflict and nutrient supply and demand hypothesis [43, 44].
However with the recent identification of developmentally important genes, including the
FGFs that regulate trophoblast survival and placental angiogenesis [45], and key epigenetic reg-
ulators, such as JMJD1Cwhich is involved in regulating early preimplantation development of
bovine embryos [46], we favor the hypothesis that maternal silencing is a mechanism to pre-
vent ovarian teratomas that arise from parthenogenetically activated oocytes [47, 48].
Our study has shown that oocyte-derivedmethylation can uniquely be maintained as
DMRs in the extra-embryonic lineages, with many placenta-specificDMRs coordinating pater-
nal expression following embryonic genome activation. Our data corroborates the observations
that these placenta-specific gDMRs can be polymorphic, with a minority of samples being
unmethylated [17]. It remains to be seen if the lack of these placenta-specificDMRs influences
pregnancy outcomes and whether they are involved in implantation and preimplantation
embryo viability.
Materials and Methods
Ethics statement
Ethical approval for the use of human placenta samples was granted by the Institutional Review
Boards at the National Center for Child Health and Development (project 234), Hospital St
Joan De Deu Ethics Committee (35/07) and Bellvitge Institute for Biomedical Research
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(PR006/08). The use of surplus human embryos for this study was evaluated and approved by
the scientific and ethic committee of the Instituto Valenciano de Infertilidad (IVI) (1310-FIVI-
131-CS), Bellvitge Institute for Biomedical Research Ethics Committee (PR292/14), the
National Committtee for Human Reproduction (CNRHA) and the Regional Health Counsel of
Valencia.
Mouse work was approved by the Institutional ReviewBoard Committees at the National
Center for Child Health and Development (approval number A2010-002).
A single placenta sample from rhesus macaque was obtained from the breeding colony of
the Biomedical Primate Research Center, Rijswijk, Netherlands using protocols approved by
the Committee on the Ethics of Animal Tissue Collection at BPRC (Permit # 730). The
EUPRIM-Net Bio-Bank is conducted and supervisedby the scientific government board along
all lines of EU regulations and in harmonization with Directive 2010/63/EU on the Protection
of Animals Used for Scientific Purposes.
Biological samples
A cohort of 72 human term placenta biopsies (gestational age 35–41 weeks gestation, average
37 weeks) from uncomplicated pregnancies with their correspondingmaternal blood samples
were collected at Hospital St Joan De Deu (Barcelona, Spain) and the National Center for Child
Health and Development (Tokyo, Japan). Written informed consent was obtained from all par-
ticipants. All placenta biopsies were collected from the fetal side around the cord insertion site.
The placenta-derivedDNA samples were free of maternal DNA contamination based on
microsatellite repeat analysis. Both DNA and RNA extractions and cDNA synthesis were car-
ried out as previously described [22].
Three surplus human blastocysts were recruited at the Fundación Instituto Valenciano de
Infertilidad (FIVI) in Valencia. The blastocysts were thawed using the Cryotopmethod follow-
ing manufacturer’s instructions [49] and incubated in CCMmedium (Vitrolife, Göteborg, Swe-
den) for 6–12 hours before microdissection in order to allow their full expansion and the inner
cell mass (ICM) and trophectoderm (TE), that were subsequently separated by micromanipu-
lation using laser technology (OCTAX, Herborn, Germany). The separated ICMs and TEs
were individually placed in PCR tubes containing 2.5 μL of PBS and immediately snap frozen
at -80°C until processing.
Wild type mouse embryos and placentas were produced by crossing C57BL/6 withMus
musculus molosinus orMus musculus castaneous mice. Animal husbandry and breeding were
conducted according to the institutional guidelines for the care and the use of laboratory
animals.
A single placenta sample from rhesus macaque (animal 95023) was obtained from the
breeding colony of the Biomedical Primate Research Center, Rijswijk, following a C-section
procedure.
Human methyl-seq data analysis
We analysed twenty-eight publicly available methylomes obtain from GEO or NBDC reposito-
ries. Two datasets were derived from human oocytes (JGAS00000000006), 5 from human
sperm (JGAS00000000006 and GSE30340), 3 from brain (GSM913595, GSM916050,
GSM1134680) 3 from CD4+ lymphocytes (GSE31263), 2 from liver (GSM916049,
GSM1134681) and individual datasets from preimplantation embryos (JGAS00000000006),
placenta (GSM1134682), muscle (GSM1010986), CD34+ cells (GSM916052), sigmoid colon
(GSM983645), lung (GSM983647), aorta (GSM983648), esophagus (GSM983649), small intes-
tine (GSM983646), pancreas (GSM983651), spleen (GSM983652), adrenal (GSM1120325) and
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adipose tissue (GSM1010983). Methylation calls were mapped to the hg19 genome. CpGmeth-
ylation values were calculated using reads from both strands as (methylated / (methylated +
unmethylmated). Only CpGs covered by at least 5 reads were considered for the analysis. For
samples with duplicates, the average of methylation was used except for oocyte samples that
present a low coverage. For this sample the methylated and unmethylated calls of the two
experiments were sum to calculate the methylation ratio. Using the cut off of 5 reads per CpG,
the coverage of all experiment vary from 89.6% up to 96.9% of all the CpGs, except for the
oocytemethylomes that cover 54.8% of CpGs sites.
Identification of germline DMRs
The methylomes for oocyte and spermwere screen with a sliding windows approach to identify
methylated and umethylated intervals.Windows were defined as 25 consecutive CpGs and was
only considered if the methylation levels was present for at least 10 CpG sites. This windows
was classifiedmethylated if mean25CpGs—1SD25CpGs> 0.75 and unmethylated if mean25CpGs +
1SD25CpGs< 0.25. Overlapping windows with the same classification were merge and allowed
us to identify 40025 unmethylated (Us) and 177787 methylated (Ms) region in sperm and
118853 unmethylated (Uo) and 102858 methylated (Mo) regions in oocyte. A germlineDMR
was identify when opposite methylated regions in sperm and oocyte overlap for more than 25
CpGs and the position defined by the overlapping difference betweenmethylated regions in
sperm and oocyte.
Identification of partially methylated regions
Intermediately methylated region in blastocysts, placenta and somatic tissues were identify
using the sliding windows approach with the following criteria 0.2<mean25CpGs +/-
1.5SD25CpGs< 0.8. Consecutivewindows on each sample were fused to generate only a single
region. A gDMR was considered to be conserved in preimplantation embryo if the gDMR over-
lap with a partially methylated region in the blastocyst dataset. To identify the gDMR that per-
sist in somatic tissues, all partiallymethylated region obtain in the 15 tissues were merge and
the number of samples partiallymethylated for each region is attribute to each region. Only
regions> 500 bp were considered to generate the partial methylation region in tissues. To be
considered as a ubiquitous gDMR, the partiallymethylated regions have to persist in the blasto-
cyst and in at least 12 somatic tissues. Placenta-specific gDMR were identifiedwhen the par-
tially methylated region is conserved at blastocyst stage but is not observed in additional tissues
methylomes. All positional annotations (CpG islands, repeats and gene locations, etc) were
obtained from UCSCweb browser and genome build hg19.
Methyl-seq analysis in other mammals
We used the methyl-seq datasets from GSE63330 that contains placenta methylation informa-
tion from rhesus macaque, dog, horse, cow and mouse [23]. The orthologous genomic intervals
associated with the 551 human oocyte-derivedgDMR that maintained an intermediate methyl-
ation profiles throughout embryonic reprogramming and in placenta were extracted using the
UCSC LiftOver function.
Allelic RNA-seq analysis
The abundance and genotypes of highly informative exonic SNPs within the transcripts flank-
ing the gDMRs that maintained an intermediate methylation profile in blastocysts were called
using Tophat v1.4.0 [50] (for the alignment) and Samtools v1.2 [51] (for the filtering and allelic
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count) in two published single cell RNA-seq datasets for preimplantation embryos (GSE44183
[18]; GSE36552 [28]). For the purpose of this study the data from individual cells were merged
to reconstruct each embryo. In the case of the GSE44183 dataset the embryonic genotypes
were compared to the accompanying paternal exome-seq data from the sperm donor’s blood
sample.
Genotyping and imprinting analysis
Genotypes of potential SNPs identified in the UCSC hg19 browser were obtained by PCR and
direct sequencing. Sequence traces were interrogated using Sequencher v4.6 (Gene Codes Cor-
poration, MI) to distinguish heterozygous and homozygous samples. Heterozygous sample sets
were analyzed for either allelic expression using RT-PCR, methylation-sensitive genotyping or
bisulphite PCR, incorporating the polymorphismwithin the final PCR amplicon so that paren-
tal alleles could be distinguished (for primer sequences see S6 Table).
Methylation-sensitive genotyping
5hmC- 5 μg of heterozygous placenta DNA was subject to DNA Glucosylation using the Epi-
mark kit (New England Biolabs) and the DNA subject to digestion with 100 units ofMsp1 for a
minimum of 8 hours at 37°C. The DNA was subject to proteinase K digestion prior to PCR.
5mC- Approximately 1 μg of heterozygous placenta DNA was digested with 10 units of
HpaII restriction endonuclease for 6 hours at 37°C. The digested DNA was subject to ethanol
precipitation and resuspended in a final volume of 20 μl TE. Approximately 50 ng of digested
DNA was used in each amplification reaction using Bioline Taq polymerase for 35–40 cycles
(for primer sequences see S6 Table). The resulting amplicons were sequenced and the
sequences traces compared to those obtained for the corresponding undigestedDNA template.
Bisulphite PCR of placenta-derived DNA
For standard bisulphite conversion approximately 1 μg DNA was subjected to sodium bisul-
phite treatment and purified using the EZ DNA methylation-Gold kit (ZYMO, Orange, CA).
Approximately 2 ul of bisulphite converted DNA was used in each amplification reaction using
Immolase Taq polymerase (Bioline) at 45 cycles and the resulting PCR product cloned into
pGEM-T easy vector (Promega) for subsequent subcloning and sequencing (for primer
sequence see S6 Table).
Nested-multiplex bisulphite PCR of embryos and oocytes
Surgically separated ICM and TE biopsies were subject to bisulphite conversion using the EZ
DNA Methylation-Direct kit (ZYMO, Orange, CA). We employed a multiplex nest PCR
approach to maximize data generation. Two sets of primers were designed to each locus and
robustly optimized in placenta-derived bisulphite DNA to ensure efficient amplification of
both methylated and unmethylated strands at a single annealing temperature without contami-
nation or the formation of primer dimer.
All subsequent outer primers (for ~20 separate loci) were co-amplified in the first reaction
using Immolase Taq polymerase (Bioline) for 45 cycles. Second round of amplifications specific
to each region, also 45 cycles, utilized locus-specific inner primers using 1ul of first round PCR
as template. All second round nested PCR products were subcloned into pGEM-T easy vector
for direct sequencing (for primer sequence see S6 Table).
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Pyrosequencing analysis for methylation quantification
Approximately 50 ng of bisulphite converted DNA was used for pyrosequencing following pre-
viously describedprotocols [22]. Standard bisulphite PCR was used to amplify the imprinted
DMRs with the exception that one primer was biotinylated (for primer sequences see S6
Table). For sequencing, forward primers were designed to the complementary strand. The pyr-
osequencing reaction was carried out on a PyroMark Q96 instrument. The peak heights were
determined using Pyro Q-CpG1.0.9 software (Biotage).
Supporting Information
S1 Fig. Analysis of candidate ubiquitous maternallymethylated gDMRs. Strand-specific
bisulphite PCR for PTCHD3, LINC00434,NPAS3, GPR78, JAKMIP1and A1BG-AS1 in various
tissues reveals inconsistent allelic methylation profiles.
(PDF)
S2 Fig. Analysis of allelicmethylation using HpaII-sensitive (5mC) andMsp1-glucosylated
(5hmC) genotyping. (A) Representative gel electrophoresis of PCR amplicons targeting pla-
centa-specificDMRs of TMEM17, FRDM3 and KCNQ1 distinguishing 5mC from 5hmC. In all
cases the resulting methylation was 5mC not 5hmC. (B) The sequence traces of PCR products
generated usingHpaII digested DNA in heterozygous placenta samples.
(PDF)
S3 Fig. Methylation profiles as determinedby methylation-sensitive genotyping. The
sequence traces of PCR products generated usingHpaII digested DNA (CCGG) reveals wide-
spread maternal methylation of 21 loci in placenta samples.
(PDF)
S4 Fig. Strand-specificbisulphite PCR and sequencing of novel placenta-specificgDMRs in
human samples. (A) Confirmation of the strand-specific and allelic methylation of 12 candi-
date DMRs by bisulphite PCR and subcloning in sperm, preimplantation embryos (separated
into ICM and TE) and term placenta biopsies. (B) Confirmation of placenta-specificDMR sta-
tus for a further 11 regions. Each circle represents a single CpG dinucleo- tide on a DNA
strand, a methylated cytosine (•) or an unmethylated cytosine (o) with the letters in the paren-
theses indicating SNP genotype. For clarity only the first 10 CpG dinucleotides are shown.
(PDF)
S5 Fig. Characterizationof the four maternallymethylated placenta-specificgDMRs associ-
ated with loci that becomehypermethylated in somatic tissues.The promoters of the
TMEM247,GPR1-AS, ZFAT and C19MCmiRNA cluster exhibit promoters that are unmethy-
lated in sperm, hypermethylated in oocytes and intermediate methylation in blastocysts and
placenta but are hypermethylated in liver (as an example of the 14 somatic tissues analyzed).
The vertical black lines in the methyl-seq tracks represent the mean methylation value for indi-
vidual CpG dinucleotides. The green boxes highlight the position of the gDMRs. Bisulphite
PCRs on placenta derived-DNA were used for confirmation. Each circle represents a single
CpG dinucleotide on a DNA strand. (•) Methylated cytosine, (o) unmethylated cytosine. Each
row corresponds to an individual cloned sequence. If informative, the parental-origin of meth-
ylation is indicated. For clarity only the first 10 CpG dinucleotides are shown.
(PDF)
S6 Fig. Strand-specificbisulphite PCR and sequencing of false-positive loci. (A) The
sequence traces of PCR products generated usingHpaII digested DNA (CCGG) reveals that
regions that appeared maternally methylated in placenta and hypermethylated in other somatic
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tissues in methyl-seq analysis are often false-positives regions (B) Bisulphite PCR and subclon-
ing showing biallelic or mosaic methylation profile for the above regions. Each circle represents
a single CpG dinucleotide on a DNA strand. (•) Methylated cytosine, (o) unmethylated cyto-
sine. Each row corresponds to an individual cloned sequence. If informative, the parental-ori-
gin of methylation is indicated. For clarity only the first 10 CpG dinucleotides are shown.
(PDF)
S7 Fig. Analysis of the orthologous sequences associatedwith human placenta-specific
DMRs in different mammalian species. (A) A heatmap showing the methylation profiles of
human placenta-specific gDMRs in methyl-seq datasets from placenta samples of rhesus
macaque, horse, cow, dog and mouse. (B) The allelic methylation of the murine orthologous
loci of human gDMRs using placenta DNA from intersubspecificmouse crosses (C57BL6/J—
B–with JF1 –J—orMus musculus castaneous–C–. Allelic RT-PCR examples of bialleic expres-
sion of Fancc and Svopl in mouse tissues. (C) Strand-specificmethylation analysis in DNA-
derived frommouse BxJF1 placenta samples for mouse gDMRs that maintain as partially
methylated regions in mouse placenta methyl-seq datasets. (D) The allelic methylation of the
rhesus macaque orthologous loci of human gDMRs. Each circle represents a single CpG dinu-
cleotide on a DNA strand, a methylated cytosine (•) or an unmethylated cytosine (o). For clar-
ity only the first 10 CpG dinucleotides are shown.
(PDF)
S8 Fig. Analysis of allelic expression for genes associatedwith novel placenta-specific
maternallymethylated gDMRs. Allelic RT-PCR analysis for eight genes located near pla-
centa-specific gDMRs in control placenta samples. Robust biallelic expression was observed in
heterozygous placenta biopsies.
(PDF)
S9 Fig. Placenta methylation profiling of regions proposed by Branco and colleagues to
influence trophoblast development. Strand-specificmethylation analysis in DNA-derived
frommouse BxC placenta samples for the promoter intervals associated with the Stk10, Scml2
and Spry1 genes.
(PDF)
S1 Table. Tissue methyl-seqprofiles of the known and candidate ubiquitous maternally
methylated gDMR regions.
(XLSX)
S2 Table. Tissue methyl-seqprofiles of oocytes-derivedand sperm-derivedgDMRs main-
taining intermediate methylation in blastocysts and placenta.The size of the placenta-spe-
cific DMRs in tabs 2 and 4 correspond to those defined by the placenta methyl-seq.
(XLSX)
S3 Table. The number of heterozygous placenta samples used to determine allelicmethyla-
tion.
(DOCX)
S4 Table. The number of heterozygous placenta samples used to determine allelic expres-
sion.
(DOCX)
S5 Table. Methyl-seq profiles for ubiquitous and placenta-specificgDMRs in both male
and female PGCs datasets.
(XLSX)
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S6 Table. A list of all primer sequenceused in this study.
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